glp-1 drugs and fatty liver The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Breakthrough GLP-1 Drug Shown to

The glucagon-like peptide 1 analogue exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice

Mudd SH, Wagner C, Luka Z, Stabler SP, Allen RH, Schroer R, Wood T, Wang J, Wong LJ (2012) Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine

Thus, it can be summarized that morphological alterations typical of eryptosis, including cell shrinkage and membrane microvesiculation, are governed by the elevation of intracellular calcium ion levels

Biotech Histochem 2014, 89 (4), 304314